FDA UDI
In Commercial Distribution
🇺🇸 United States
Virtual Kit Number
DI: 04033817901617
·
Model: B-Capta FULL SYSTEM
·
LivaNova Deutschland GmbH
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1
Basic Information
- Brand Name
- Virtual Kit Number
- Primary DI
- 04033817901617
- Version / Model
- B-Capta FULL SYSTEM
- Company Name
- LivaNova Deutschland GmbH
- Labeler DUNS
- 343225272
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 1
- Record Status
- Published
- Publish Date
- 2021-05-14
- Public Version
- 1
- Public Version Date
- 2021-05-24
- Public Version Status
- New
- Public Device Record Key
- 59b5aa76-fa9d-410a-90df-9a7d5ee32ca8
Device Characteristics
- Single Use
- No
- Prescription Use (Rx)
- Yes
- Over the Counter (OTC)
- No
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- Yes
- Has Lot/Batch Number
- No
- Has Manufacturing Date
- No
- Has Expiration Date
- No
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| DRY | MONITOR, BLOOD-GAS, ON-LINE, CARDIOPULMONARY BYPASS | Cardiovascular | 870.4330 | 2 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 37238 | Extracorporeal blood gas/pH monitor | A mains electricity (AC-powered) device designed for the continuous measurement and display of blood gas and related parameters when blood is circulated outside of the body in a closed system. It is typically used with an appropriate sensor or sensor cassette inserted into external tubing to measure parameters such as partial pressure of oxygen (pO2), partial pressure of carbon dioxide (pCO2), pH, temperature, haemoglobin (Hb), and hematocrit (Hct). It is typically used with a cardiopulmonary bypass system, or bedside for a patient with respiratory failure (e.g., obstructive lung disease, severe asthma) or severe pulmonary hypertension after cardiac surgery. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Primary | 04033817901617 | GS1 |
Premarket Submissions
| Submission Number | Supplement Number |
|---|---|
| K202154 | 000 |